Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
Magnetic resonance imaging (MRI) contrast agents (CAs) are chemical compounds that can enhance image contrast on T1- or T2- weighted MR image. We have previously demonstrated the potential of MnCl2, a manganese-based CA, in cellular imaging of breast cancer using T1-weighted MRI. In this work, we ex...
Saved in:
| Main Authors: | Mosa Alhamami, Weiran Cheng, Yuanyuan Lyu, Christine Allen, Xiao-An Zhang, Hai-Ling Cheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0196998&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Noninvasive Manganese-Enhanced Magnetic Resonance Imaging for Early Detection of Breast Cancer Metastatic Potential
by: Joris Tchouala Nofiele, et al.
Published: (2014-01-01) -
Manganese Porphyrin Treatment Improves Redox Status Caused by Acute Compressive Spinal Cord Trauma
by: Raquel Vieira Niella, et al.
Published: (2025-05-01) -
Porphyrin-based metal-organic frameworks for cancer theranostics
by: Liandi Guan, et al.
Published: (2024-12-01) -
Radiomics Integration of Mammography and DCE-MRI for Predicting Molecular Subtypes in Breast Cancer Patients
by: Yang X, et al.
Published: (2025-02-01) -
Multi-parametric quantitative MRI reveals three different white matter subtypes.
by: Jack R Foucher, et al.
Published: (2018-01-01)